Insmed Inc  (INSM)
Other Ticker:  
   Industry ../Industry/Industry_Growth.php?ind=803"> Major Pharmaceutical Preparations
   Sector  Healthcare
Price: $17.0200 $-0.40 -2.296%
Day's High: $17.63 Week Perf: -7.1 %
Day's Low: $ 16.96 30 Day Perf: -13.78 %
Volume (M): 1,284 52 Wk High: $ 28.94
Volume (M$): $ 21,854 52 Wk Avg: $21.15
Open: $17.43 52 Wk Low: $16.41

 Market Capitalization (Millions $) 2,096
 Shares Outstanding (Millions) 123
 Employees -
 Revenues (TTM) (Millions $) 244
 Net Income (TTM) (Millions $) -482
 Cash Flow (TTM) (Millions $) 357
 Capital Exp. (TTM) (Millions $) 10

Insmed Inc

   Company Address: 700 US Highway 202/206 Bridgewater 8807 NJ
   Company Phone Number: 977-9900   Stock Exchange / Ticker: NASDAQ INSM
   INSM is expected to report next financial results on May 04, 2023.


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Enzo Biochem Inc

Very steep Deterioration at ENZ over the financial time-frame ending January 31 2023

the Medical Laboratories company disclosed disastrous financial time-frame ending January 31 2023, where Sales faded by -52.012 % to $16.34 millions and net deficit per share has extended to $-0.23, from the corresponding quarter a year ago.

Chemomab Therapeutics Ltd

Chemomab Therapeutics Ltd announced operating shortfall of $-8.642 millions, in the fourth quarter of 2022 financial report

The Major Pharmaceutical Preparations sector contributors begin to analyze the fourth quarter of 2022 numbers. Today they observe operating shortfall of $-8.642 millions, from the Chemomab Therapeutics Ltd , as it hasn't cited any revenue still, for the own October to December 31 2022 reporting period.

Eterna Therapeutics Inc

The Major Pharmaceutical Preparations company added good news for the shareholders, exhibiting a genuine gain in fiscal fourth quarter of 2022 with operating loss of $-4.737 millions

The shareholders have not expected some adjustments at the top-line throughout the the earnings season of the October to December 31 2022 season at the ERNA. But, stockholders observe the company's operating loss that was at $-4.737 millions, during the same period.

Camtek Ltd

CAMT delivered bewildering fourth quarter of 2022 Sales and earnings growth , where Sales grew by 19.005 % to $320.91 millions when compared with the prior year period, earnings were up by 23.88 % at $1.66 per share.

Exagen Inc

Exagen Inc reported that Sales went up slight, during the October to December 31 2022 interval

For the financial interval ending December 31 2022 XGN increased a shortfall per share of $-0.83 per share compare to $-0.41 a year before and grew shortfall from $-0.47 per share from the preceding financial reporting period.

Sales grew slightly by 1.166 % to $12.84 millions from $12.69 millions in the similar financial reporting period a year before and sequentially Sales deteriorated by -12.828 % from $14.73 millions.


Insmed Inc's Segments
• View Complete Report


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

ISPO's Profile

Stock Price

ISPO's Financials

Business Description


Charts & Quotes

ISPO's News


ISPO's Competitors

Customers & Markets

Economic Indicators

ISPO's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries




At a Glance








About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071